Alfred P. Spada
2013
In 2013, Alfred P. Spada earned a total compensation of $399.8K as Executive Vice President, Research and Development, and Chief Scientific Officer at Conatus Pharmaceuticals, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $99,089 |
|---|---|
| Salary | $283,112 |
| Other | $17,578 |
| Total | $399,779 |
Spada received $283.1K in salary, accounting for 71% of the total pay in 2013.
Spada also received $99.1K in non-equity incentive plan and $17.6K in other compensation.
Rankings
In 2013, Alfred P. Spada's compensation ranked 10,058th out of 12,286 executives tracked by ExecPay. In other words, Spada earned more than 18.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,058 out of 12,286 | 18th |
Division Manufacturing | 3,741 out of 4,612 | 19th |
Major group Chemicals And Allied Products | 1,190 out of 1,462 | 19th |
Industry group Drugs | 932 out of 1,156 | 19th |
Industry Pharmaceutical Preparations | 725 out of 890 | 19th |
Source: SEC filing on April 28, 2015.
Spada's colleagues
We found two more compensation records of executives who worked with Alfred P. Spada at Conatus Pharmaceuticals in 2013.